Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage III
Interventions: DRUG: Isosulfan Blue|PROCEDURE: Axillary Lymph Node Dissection|PROCEDURE: Mapping|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)